Measures to help breast cancer patients avoid premature menopause.

Australian researchers announced on May 31st that they have discovered a new method that could help breast cancer patients avoid the risk of premature menopause.

After conducting research on 218 women in various parts of the world, experts from the Peter MacCallum Cancer Centre in Melbourne found that regular monthly injections of goserelin helped reduce the temporary symptoms of menopause.

Patients who regularly use goserelin during chemotherapy have a 64% reduced risk of premature menopause. Their chances of still being able to have children after cancer treatment are also nearly doubled compared to those who do not use goserelin.

Experts affirm that this is an important finding for breast cancer patients, especially younger patients. According to statistics, approximately 800 women in Australia are diagnosed with breast cancer before the age of 40.

In recent years, breast cancer has been considered one of the most common cancers in women, especially those in the pre-menopausal or post-menopausal age group.

This is also the leading cause of death among all cancers. It is estimated that there are approximately 12 million cases of cancer worldwide each year, of which 1.4 million are breast cancer.

The World Health Organization has warned that if preventive measures, early diagnosis, and appropriate lifestyle changes are not promptly strengthened, by 2025, 19 million women worldwide will have breast cancer.

According to Vietnam+